ViewMind Inc.See brain health clearly through the eyes

ViewMind

ViewMind is revolutionizing brain health diagnostics through precision measurement of ocular movement alterations. By combining non-invasive eye-tracking technology with advanced AI analytics, ViewMind provides early detection of neurocognitive conditions that traditional methods often miss. This scalable solution addresses the critical gap in neurological care where 1 billion people worldwide suffer from brain disorders.

Product Highlights

• Non-Invasive Assessment: Uses head-mounted displays with eye-tracking sensors—no blood draws, imaging radiation, or invasive procedures required
• Patented Digital Phenotyping: Advanced statistical models analyze numerous eye movement permutations to detect minor cognitive alterations with high sensitivity and specificity
• Cognitive Domain Mapping: Measures neurocognitive health by specific cognitive domains and their corresponding brain regions for precise localization
• Scalable Deployment: Affordable and accessible solution suitable for widespread screening in clinics, hospitals, and elderly care centers

Use Cases

• Pharmaceutical Clinical Trials: Pre-screen study participants, cognitively match cohorts, and measure drug impact on cognitive health to improve the low 6.2% FDA approval rate for CNS drugs
• Healthcare Monitoring: Enable physicians to assess and monitor patient brain health over time, tracking treatment effectiveness and disease progression
• Early Disease Detection: Identify neurological conditions before symptoms become apparent, when intervention can be most effective

Target Audience

ViewMind serves pharmaceutical companies developing central nervous system treatments, healthcare institutions seeking better brain health diagnostics, and medical professionals in neurology, psychiatry, and geriatric care who need sensitive, non-invasive cognitive assessment tools.